Therefore, considering the key link between neutrophil overactivation and the cytokine storm in COVID-19, as well as the key role of NF-κB, naringenin represents an interesting natural option for the treatment of patients with comorbidities or severe cases of SARS-CoV-2 infection. This evidence concerns the gene NFKB1 and COVID-19.